Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationStem CellsMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanCombined Modality TherapyGraft vs Host DiseaseTreatment OutcomeRemission InductionSalvage TherapyBone Marrow TransplantationMyeloablative AgonistsHematologic NeoplasmsDisease-Free SurvivalRecurrenceCyclophosphamideHematopoietic Stem CellsHodgkin DiseaseEtoposideHematopoietic Stem Cell MobilizationCytarabineSurvival RateLymphoma, Non-HodgkinBusulfanSurvival AnalysisCarmustineWhole-Body IrradiationRetrospective StudiesVincristineTransplantation ChimeraThiotepaBone Marrow PurgingGraft SurvivalLymphoma, Mantle-CellPrognosisEmbryonic Stem CellsAntigens, CD34Tissue DonorsFollow-Up StudiesAmyloidosisMesenchymal Stem Cell TransplantationDoxorubicinBone and BonesAntibodies, Monoclonal, Murine-DerivedLeukemia, Myeloid, AcuteTime FactorsBoronic AcidsDexamethasoneAdult Stem CellsLymphoma, FollicularNeoplasm, ResidualAntineoplastic AgentsPyrazinesGraft vs Leukemia EffectGranulocyte Colony-Stimulating FactorThalidomideAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesHistocompatibility TestingVidarabineLymphoma, T-Cell, PeripheralAutograftsCord Blood Stem Cell TransplantationLymphomaLiver TransplantationGraft vs Tumor EffectIfosfamideImmunosuppressive AgentsBone MarrowLeukapheresisLeukemiaInduction ChemotherapyPluripotent Stem CellsBone Marrow CellsCell DifferentiationPrednisonePodophyllotoxinMesenchymal Stromal CellsStem Cell NicheCell TransplantationLymphoma, Large B-Cell, DiffuseHistocompatibilityMaintenance ChemotherapyLymphocyte TransfusionPrecursor Cell Lymphoblastic Leukemia-LymphomaNeural Stem CellsT-LymphocytesLeukemia, MyeloidProspective StudiesCytomegalovirus InfectionsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseAntibodies, MonoclonalInduced Pluripotent Stem CellsSiblings